Alamar Capital Management LLC Purchases New Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Alamar Capital Management acquired 8,491 HCA Healthcare shares worth approximately $3.31 million in the second quarter, making HCA its ninth-largest portfolio holding. Institutional investors collectively own 62.73% of the company.
• HCA reported quarterly EPS of $7.59, slightly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. Analysts expect full-year EPS of approximately $29.47.
• HCA declared a quarterly dividend of $0.78 per share, equivalent to a $3.12 annualized payout and a 0.8% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $465.59.

Alamar Capital Management LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 8,491 shares of the company's stock, valued at approximately $3,311,000. HCA Healthcare accounts for approximately 1.7% of Alamar Capital Management LLC's investment portfolio, making the stock its 9th biggest position.

Several other institutional investors also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth about $26,000. MidFirst Bank bought a new position in HCA Healthcare in the 2nd quarter worth approximately $28,000. Clearstead Trust LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth $31,000. Finally, Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $33,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Up 1.8%

HCA opened at $412.27 on Wednesday. The business's fifty day simple moving average is $395.07 and its 200 day simple moving average is $445.35. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The stock has a market cap of $89.26 billion, a PE ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business earned $6.84 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is presently 10.45%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HCA shares. Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Robert W. Baird decreased their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a report on Monday, July 27th. Leerink Partners cut their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a report on Monday, April 27th. Cantor Fitzgerald lowered their price objective on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a research report on Tuesday, July 7th. Finally, JPMorgan Chase & Co. reduced their target price on HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating for the company in a research report on Tuesday, May 19th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $465.59.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source